Sign in

CIK 0001655759

  • Accelerated filer

ARVINAS, INC.

Sign in to watch
Ticker
ARVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472566120
Phone
+1 203-535-1456
Business address
395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
Former names
ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
  1. 4 Grant or award Chief Medical Officer acquired 45,000 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 45,000 shares (grant or award)
  3. 4 Grant or award President and CEO acquired 147,791 shares (grant or award)
  4. 4 Open-market sale Director sold 35,297 shares at an average $13.21 ($466,154)
  5. 4 Open-market sale Chief Accounting Officer sold 1,108 shares at $12.16 ($13,473)
  6. 4 Open-market sale Chief Scientific Officer sold 3,609 shares at $12.16 ($43,885)
  7. 4 Open-market sale President and CEO sold 4,786 shares at $12.16 ($58,198)
  8. 4 Open-market sale President and CEO sold 4,403 shares at $11.89 ($52,352)
  9. 4 Open-market sale Chief Financial Officer sold 5,134 shares at $11.89 ($61,043)
  10. 4 Open-market sale Chief Scientific Officer sold 4,592 shares at $11.89 ($54,599)
  11. 4 Open-market sale Chief Medical Officer sold 5,685 shares at $11.89 ($67,595)
  12. 4 Open-market sale Chief Accounting Officer sold 1,016 shares at $11.89 ($12,080)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale Chief Accounting Officer sold 230 shares at $9.89 ($2,275)
  15. 4 Open-market buy Director bought 30,000 shares at $7.57 ($227,010)
  16. 4 Grant or award Director acquired 16,025 shares (grant or award)
  17. 4 Grant or award Director acquired 16,025 shares (grant or award)
  18. 4 Grant or award Director acquired 16,025 shares (grant or award)
  19. 4 Grant or award Director acquired 16,025 shares (grant or award)
  20. 4 Grant or award Director acquired 16,025 shares (grant or award)

Page 2 of 15 · 285 filings